Discontinuation report RATIO-NYSTATIN
Report ID | 97261 |
Drug Identification Number | 02194236 |
Brand name | RATIO-NYSTATIN |
Common or Proper name | NYSTATIN |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | NYSTATIN |
Strength(s) | 100000UNIT |
Dosage form(s) | CREAM |
Route of administration | TOPICAL |
Packaging size | 15ml |
ATC code | D01AA |
ATC description | ANTIFUNGALS FOR TOPICAL USE |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2019-10-25 |
Remaining supply date | 2019-10-25 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2019-10-26 | English | Compare |
v2 | 2019-10-25 | French | Compare |
v1 | 2019-10-25 | English | Compare |
Showing 1 to 3 of 3